Cargando…
History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies
Autores principales: | Djulbegovic, Mia, Gevorgian, Melinda, Luning-Prak, Eline, Garfall, Alfred L., Vogl, Dan T., Cohen, Adam D., Waxman, Adam, Susanibar, Sandra, Stadtmauer, Edward A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930031/ http://dx.doi.org/10.1016/S2666-6367(22)00592-9 |
Ejemplares similares
-
Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis
por: Bernabei, Luca, et al.
Publicado: (2019) -
The analysis of clonal expansions in normal and autoimmune B cell repertoires
por: Hershberg, Uri, et al.
Publicado: (2015) -
Trials and Tribulations with VH Replacement
por: Meng, Wenzhao, et al.
Publicado: (2014) -
DNA Damage and L1 Retrotransposition
por: Farkash, Evan A., et al.
Publicado: (2006) -
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
por: Shan, Xinhe, et al.
Publicado: (2023)